A new survey on translational processes and hurdles to clinical trials in Longevity biotech.
We’re working with two MDs: Oliver Zolman and Jian Fransen, on a confidential 10-minute survey to help identify the barriers that innovators are facing in bringing Longevity biotech innovations to market.
We will, of course, be sharing the top-level results and we hope the survey will help identify which of the four key innovation risk areas that aging biotech is most exposed to:
Following the 10-minute survey, and only as a value-add option, Oliver and Jian are offering a confidential follow-up call to help analyse your answers and craft a personalised risk profile for your business.
Thanks in advance to our respondents!